BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15828235)

  • 1. [The roles of PPARs in digestive diseases].
    Nakajima A; Yoneda M; Takahashi H; Fujisawa N; Wada K
    Nihon Rinsho; 2005 Apr; 63(4):665-71. PubMed ID: 15828235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Roles of PPARs in carcinogenesis].
    Imamura K; Lu J; Kaminishi M
    Nihon Rinsho; 2005 Apr; 63(4):584-8. PubMed ID: 15828224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR receptor activation: Experimental studies on cardiac structure and function.
    Bishop-Bailey D
    Curr Opin Investig Drugs; 2010 Mar; 11(3):283-8. PubMed ID: 20178041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PPARs-mediated intracellular signal transduction].
    Fujii H
    Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARgamma as a new therapeutic target in inflammatory bowel diseases.
    Dubuquoy L; Rousseaux C; Thuru X; Peyrin-Biroulet L; Romano O; Chavatte P; Chamaillard M; Desreumaux P
    Gut; 2006 Sep; 55(9):1341-9. PubMed ID: 16905700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma is essential for protection against nonalcoholic steatohepatitis.
    Wu CW; Chu ES; Lam CN; Cheng AS; Lee CW; Wong VW; Sung JJ; Yu J
    Gene Ther; 2010 Jun; 17(6):790-8. PubMed ID: 20376096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors: new players in the field of reproduction.
    Toth B; Hornung D; Scholz C; Djalali S; Friese K; Jeschke U
    Am J Reprod Immunol; 2007 Sep; 58(3):289-310. PubMed ID: 17681045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition.
    Froment P; Gizard F; Defever D; Staels B; Dupont J; Monget P
    J Endocrinol; 2006 May; 189(2):199-209. PubMed ID: 16648288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PPAR and diabetes].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2005 Apr; 63(4):623-9. PubMed ID: 15828230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro.
    Downie MM; Sanders DA; Maier LM; Stock DM; Kealey T
    Br J Dermatol; 2004 Oct; 151(4):766-75. PubMed ID: 15491415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARs and the placenta.
    Fournier T; Tsatsaris V; Handschuh K; Evain-Brion D
    Placenta; 2007; 28(2-3):65-76. PubMed ID: 16834993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
    George J; Liddle C
    Mol Pharm; 2008; 5(1):49-59. PubMed ID: 18072723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and PPAR insulin sensitizers.
    Bhatia V; Viswanathan P
    Curr Opin Investig Drugs; 2006 Oct; 7(10):891-7. PubMed ID: 17086933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The structures and functions of peroxisome proliferator-activated receptors (PPARs)].
    Takahashi N; Goto T; Kusudo T; Moriyama T; Kawada T
    Nihon Rinsho; 2005 Apr; 63(4):557-64. PubMed ID: 15828220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PPARs and cell-cell or cell-extracellular matrix interactions].
    Murad H; Fiatte C; Brunner E; Huin-Schohn C; Schohn H; Bécuwe P; Domenjoud L; Dauça M
    Med Sci (Paris); 2007 May; 23(5):515-8. PubMed ID: 17502068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PPARs and heart diseases].
    Takano H; Komuro I
    Nihon Rinsho; 2005 Apr; 63(4):659-64. PubMed ID: 15828234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.